KV

Kantilal Vajeraj Jain

Active Director Director DIN 00316736
DIN 00316736 First appointment Jul 1981 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Total affiliations 4 Since Jul 1981
Shareholding value •••• Premium profile

About Kantilal Vajeraj Jain

Data last updated:

Kantilal Vajeraj Jain is a Director at Lark Laboratories (India) Ltd (since 1981), Director at Embiotic Laboratories Private Limited (since 1988) and Partner at Embiotic Lifesciences Llp (since 2026), and holds 1 more current directorship. The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹117 Cr; the largest is Lark Laboratories (India) Ltd at ₹77.99 Cr (FY 2024).

DIN 00316736
Primary Designation Director
Industry Pharma
First Appointment 11 Jul 1981
Oldest Company Age 47 yrs
Largest company Lark Laboratories (India) Ltd · ₹77.99 Cr (FY 2024)
Combined revenue ₹117 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lark Laboratories (India) Ltd U24230DL1979PLC009548
Director11 Jul 19811979₹77.99 Cr (FY 2024)Active
Director29 Aug 19881988₹39.29 Cr (FY 2025)Active
Partner27 Aug 20262026Active
Partner09 Jul 20262026Active

Directorship timeline

Open interactive timeline →
Lark Laboratories (India) Ltd
Embiotic Laboratories Private Limited
Therazen India Llp
Embiotic Lifesciences Llp
Premium access

Shareholding and investment profile for Kantilal Vajeraj Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kantilal Vajeraj Jain

Kantilal Vajeraj Jain currently holds 4 directorships: Lark Laboratories (India) Ltd (Director, since 11 Jul 1981, revenue ₹77.99 Cr (FY 2024)); Embiotic Laboratories Private Limited (Director, since 29 Aug 1988, revenue ₹39.29 Cr (FY 2025)); Embiotic Lifesciences Llp (Partner, since 27 Aug 2026); Therazen India Llp (Partner, since 09 Jul 2026).

Kantilal Vajeraj Jain was first appointed on 11 Jul 1981 as Director at Lark Laboratories (India) Ltd. The most recent appointment on record is 27 Aug 2026 at Embiotic Lifesciences Llp.

The 2 current companies of Kantilal Vajeraj Jain that report revenue have a combined latest revenue of ₹117 Cr: Lark Laboratories (India) Ltd ₹77.99 Cr (FY 2024); Embiotic Laboratories Private Limited ₹39.29 Cr (FY 2025).

The current boards of Kantilal Vajeraj Jain's companies include Aprajita Takiar (Lark Laboratories (India) Ltd), Badri Bishal Tikmani (Lark Laboratories (India) Ltd), Kamal Prabha Anand (Lark Laboratories (India) Ltd), Vijay Kumar Gupta (Lark Laboratories (India) Ltd), Vijay Uppal (Lark Laboratories (India) Ltd), Virender Uppal (Lark Laboratories (India) Ltd), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available